Medscape3d
Safety and Efficacy of Combined Long-Acting Beta-Agonists and Inhaled Corticosteroids vs Long-Acting Beta-Agonists Monotherapy for Stable COPD
Background: Current guidelines recommend the use of inhaled corticosteroids (ICSs ... the safety and efficacy of LABAs/ICSs compared with LABA monotherapy for patients with moderate-to-very ...
pharmaphorum9d
Novartis’ COPD combo show benefits in switching from established drugs
The CRYSTAL study is the first LABA/LAMA pragmatic trial ... to Ultibro Breezhaler from other COPD treatments, such as inhaled steroid-containing combination therapies," said Vasant Narasimhan ...
pharmaphorum9y
Boehringer's Spiolto tops Seretide in head-to-head COPD trial
are among the first data to show that a combination of a long-acting muscarinic antagonist (LAMA) and long-acting beta agonist (LABA) is more effective than a LABA combined with an inhaled ...